Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV
- PMID: 29198180
- DOI: 10.1177/0956462417740487
Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV
Abstract
Adolescents in Africa are at high risk for HIV infection, other sexually transmitted infections (STIs) and bacterial vaginosis (BV). Since behavior and burden of STIs/BV may influence HIV risk, behavioral risk factors and prevalence of STIs/BV were compared in HIV-seronegative adolescent females (n = 298; 16-22 years) from two South African communities (Soweto and Cape Town). STIs ( Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, herpes simplex virus (HSV)-1, HSV-2, Treponema pallidum, and Haemophilus ducreyi) were detected by multiplex polymerase chain reaction, human papillomavirus (HPV) by Roche Linear Array, and BV by Nugent scoring. Rates of BV (Nugent ≥7; 46.6%) and HPV (66.8%) were high in both communities. Prevalence of C. trachomatis and N. gonorrhoeae were >2-fold higher in Cape Town than Soweto (Chlamydia: 42% [62/149] versus 18% [26/148], p < 0.0001; gonorrhoea 11% [17/149] versus 5% [7/148], p = 0.05). Only 24% of adolescents with vaginal discharge-causing STIs or BV were symptomatic. In South African adolescents, clinical symptoms compatible with vaginal discharge syndrome had a sensitivity of 23% and specificity of 85% for the diagnosis of discharge-causing STI or BV. In a region with high HIV prevalence and incidence, >70% of young women with treatable conditions that could enhance HIV risk would have been missed because they lacked symptoms associated with syndromic management.
Keywords: Female; adolescents; bacterial vaginosis; sexually transmitted infections; syndromic management.
Similar articles
-
Molecular Identification of Cervical Microbes in HIV-Negative and HIV-Positive Women in an African Setting Using a Customized Bacterial Vaginosis Microbial DNA Quantitative PCR (qPCR) Array.Microbiol Spectr. 2022 Jun 29;10(3):e0222921. doi: 10.1128/spectrum.02229-21. Epub 2022 Jun 1. Microbiol Spectr. 2022. PMID: 35647888 Free PMC article.
-
Sexually transmitted infections and bacterial vaginosis among adolescent girls and young women in the early postpartum period: a cross-sectional study.BMC Infect Dis. 2024 Sep 2;24(1):898. doi: 10.1186/s12879-024-09781-4. BMC Infect Dis. 2024. PMID: 39223449 Free PMC article.
-
Prevalent bacterial vaginosis infection - a risk factor for incident sexually transmitted infections in women in Durban, South Africa.Int J STD AIDS. 2016 Dec;27(14):1283-1288. doi: 10.1177/0956462415616038. Epub 2015 Nov 3. Int J STD AIDS. 2016. PMID: 26538552
-
Bacterial vaginosis-A brief synopsis of the literature.Eur J Obstet Gynecol Reprod Biol. 2020 Feb;245:143-148. doi: 10.1016/j.ejogrb.2019.12.035. Epub 2019 Dec 24. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 31901667 Free PMC article. Review.
-
Population-based interventions for reducing sexually transmitted infections, including HIV infection.Cochrane Database Syst Rev. 2001;(2):CD001220. doi: 10.1002/14651858.CD001220. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2004;(2):CD001220. doi: 10.1002/14651858.CD001220.pub2. PMID: 11405980 Updated. Review.
Cited by
-
How the Cervical Microbiota Contributes to Cervical Cancer Risk in Sub-Saharan Africa.Front Cell Infect Microbiol. 2020 Feb 12;10:23. doi: 10.3389/fcimb.2020.00023. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32117800 Free PMC article. Review.
-
Antimicrobial and inflammatory properties of South African clinical Lactobacillus isolates and vaginal probiotics.Sci Rep. 2019 Feb 13;9(1):1917. doi: 10.1038/s41598-018-38253-4. Sci Rep. 2019. PMID: 30760770 Free PMC article. Clinical Trial.
-
Prevalence of Curable Sexually Transmitted Infections in a Population-Representative Sample of Young Adults in a High HIV Incidence Area in South Africa.Sex Transm Dis. 2023 Dec 1;50(12):796-803. doi: 10.1097/OLQ.0000000000001871. Epub 2023 Oct 8. Sex Transm Dis. 2023. PMID: 37944161 Free PMC article. Clinical Trial.
-
An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.BMC Infect Dis. 2019 Sep 18;19(1):824. doi: 10.1186/s12879-019-4425-1. BMC Infect Dis. 2019. PMID: 31533663 Free PMC article. Clinical Trial.
-
Effects of enhanced STI partner notification counselling and provider-assisted partner services on partner referral and the incidence of STI diagnosis in Cape Town, South Africa: randomised controlled trial.Sex Transm Infect. 2021 Feb;97(1):38-44. doi: 10.1136/sextrans-2020-054499. Epub 2020 Jun 1. Sex Transm Infect. 2021. PMID: 32482641 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical